Contrast Media Injectors Market To Surpass US$ 2,000.7 Million By 2027 - Coherent Market Insights

1. CONTRAST MEDIA INJECTORS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Contrast Media Injectors Market - Overview Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in tissues. MRI injectors are used to insert contrast media into the vascular system prior to MRI scan. These devices typically consist of automated electromechanical injectors with syringes that may be either reusable, disposable, or both. One unit refers to one MRI injector. MRI injectors are slightly costlier than CT injectors. The global Contrast Media Injectors Market is estimated to account for US$ 2,000.7 Mn in terms of value and 49,381 Units in terms of volume by the end of 2027. Global Contrast Media Injectors Market: Drivers Increasing prevalence of cardiovascular diseases (CVDs) is expected to boost growth of the global Contrast Media Injectors Market over the forecast period. For instance, according to American Heart Association (AHA) 2018 update on heart disease and stroke statistics, coronary heart disease (CHD) (43.8%) is the leading cause of deaths attributable to CVDs in the US and by 2035, over 130 million adults in the US are expected to have some form of CVD. Global Contrast Media Injectors Market: Opportunities Increasing geriatric population is expected to offer lucrative growth opportunities for the market players. For instance, according to the World Health Organization, the proportion of the world's population over 60 years is expected to increase from 12% to 22%. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/contrast- media-injectors-market-3157 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Contrast Media Injectors Market: Restraints A serious issue faced during contrast media injection is air emboli formation, which results from large air infusion that creates an air lock in the pulmonary artery, causing blood pressure to drop abruptly, followed, by cardiovascular collapse. This in turn is expected to hamper growth of the global contrast media injectors market. Key Takeaways: The CT Injectors segment in the global contrast media injectors market was valued at US$ 514.4 Mn in 2018 and is expected to reach US$ 864.6 Mn by 2027 at a CAGR of 6.0% during the forecast period. The growth of the segment is attributed to increasing incidence of chronic diseases the hospitals segment held dominant position in the global contrast media injectors market in 2018, accounting for 48.9% share in terms of volume, followed by ambulatory surgical centers, respectively. Increasing healthcare infrastructure in developing economies is expected to drive the growth of the market during the forecast period. For instance, in December 2019, Guerbet received registration for its innovative conventional Trans-Arterial Chemo-Embolization (cTACE) mixing and injection system, Vectorio, in India from the Ministry of Health & Family Welfare. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3157 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The market is also witnessing increasing M&A activities. For instance, in August 2019, Bracco Imaging acquired Blue Earth Diagnostics, a molecular imaging company based in U.K. from Syncona Ltd. Global Contrast Media Injectors Market: Competitive Landscape Major players operating in the global contrast media injectors market include, General Electric, Mallinckrodt, Guerbet SA, Bayer AG, Bracco Imaging S.p.A., Ulrich GmbH & Co. KG, Medtron, and Nemoto Kyorindo Co. Ltd. Global Contrast Media Injectors Market: Key Developments Key players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in November 2019, Guerbet received approval for a new indication for Lipiodol Ultra Fluid in Denmark for chemoembolization (cTACE) of tumors in adults with known intermediate-stage hepatocellular carcinoma. Key players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in March 3, 2018, Bracco Imaging S.p.A. partnered with R.A.W. S.r.l. - an Italy-based company focused on Augmented Reality Guidance technology in Interventional Oncology procedures - to expand its portfolio of solutions for Interventional Oncology. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3157 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved